8,274 trials (keyword fallback)
Kohlmeier Degos Disease With Neurologic Involvement · Kohlmeier-Degos Disease
Primary: Number of Participants With Stable or no Lesions Developed Based on MRI Neurological Involvement of K-D Disease Following Ruloxitinib — 1; 0; 0 Participants
Behcet Disease
Primary: Number of Participants With Attacks — 0 Participants
Cardiac Disease · Dementia · Inflammatory Disease
Primary: Overall Image Quality Scores
Alzheimer Disease · Mild Cognitive Impairment · Memory Disorders
Primary: Change in Diagnostic Area Under the Receiver Operating Characteristic Curve (ROC-AUC) — 0.94; 0.91 probability
Glioma
Primary: Task Completing Time Change Between Sedation and Baseline Measured by 9-hole Peg Test — 27.8; 19.1; 54.3; 21.4 seconds — p=<0.01
Transverse Myelitis · Neuromyelitis Optica · Idiopathic Transverse Myelitis
Primary: Walking Speed During Timed 25-foot Walk — 0.3342; 0.4745; 0.4593; 0.1743 feet/second
Acute Ischemic Stroke
Primary: Analysis of the National Institutes of Health Stroke Scale (NIHSS) Total Score Area Under the Curve During the Treatment Period — 3.83; 3.13 units on a scale
Shoulder Instability · Iatrogenic Nerve Injury
Primary: Neurologic Complication Rate After Latarjet Procedure — 7 participants
Mild Traumatic Brain Injury · Concussion
Primary: The Feasibility of Inpatient Bedside Neurocognitive Testing of Pediatric Patients With Minor Traumatic Brain Injury. — 120 participants
HIV Infections
Primary: Number of Participants With Occurrence of Seizure — 0; 1 Participants
Adrenoleukodystrophy · Metachromatic Leukodystrophy · Globoid Cell Leukodystrophy
Primary: Number of Patients With Donor Cell Engraftment — 26 Participants
Sarcoidosis
Primary: Change From Baseline in Percent-predicted Forced Vital Capacity (FVC) at Week 16 — 2.02; 1.15; -0.15 percent of predicted FVC — p=0.543
Cerebral Stroke
Primary: Motor Control — 413.22; 523.94 1/s^2
Spinocerebellar Ataxias · Tai Chi
Primary: Scale for the Assessment and Rating of Ataxia(SARA) — 11.5; 9 score on a scale
Brain Diseases, Metabolic, Inborn · Urea Cycle Disorder · Ornithine Transcarbamylase Deficiency
Primary: Concentration of Glutamine and Myoinositol by MRS — 4.97; 3.66; 3.78; 4.50 mM — p=0.003